MOS

Renuvis Enzara™ from Mosaic Biosciences ®  helps growers break down heavy residue faster to reach plant-ready conditions sooner TAMPA, Fla., Aug. 17, 2026 /PRNewswire/ -- Mosaic Biosciences® today announced the launch of Renuvis Enzara™, an innovative residue management solution designed to help growers accelerate the natural decomposition of crop residue and support more consistent, plant-ready field conditions.

TAMPA, Fla., Aug. 17, 2026 /PRNewswire/ -- The Mosaic Company (NYSE: MOS) ("Mosaic") today announced the expiration and final results of  its previously announced cash tender offers (collectively, the "Offers") to purchase the outstanding 4.050% Senior Notes due 2027 (the "2027 Notes"), 7.30% Debentures due 2028 (the "2028 Debentures"), 5.375% Senior Notes due 2028 (the "2028 Notes") and 4.350% Senior Notes due 2029 (the "2029 Notes") and together with the 2027 Notes, 2028 Debentures and 2028 Notes, the "Notes," and each a "Series of Notes"), in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated August 10, 2026 (the "Offer to Purchase") and any related documents (collectively with the Offer to Purchase, the "Tender Offer Documents").

TAMPA, Fla., Aug. 14, 2026 /PRNewswire/ -- The Mosaic Company (NYSE: MOS) ("Mosaic") today announced the Reference Yield and Total Consideration (as set forth in the table below) to be paid in connection with its previously announced cash tender offers (collectively, the "Offers") to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated August 10, 2026 (the "Offer to Purchase").

TAMPA, Fla., Aug. 10, 2026 /PRNewswire/ -- The Mosaic Company (NYSE: MOS) ("Mosaic") today announced that it has commenced cash tender offers (collectively, the "Offers") to purchase the outstanding notes described below, in each case upon the terms and subject to the conditions set forth in the Offer to Purchase dated August 10, 2026 (the "Offer to Purchase").

The Mosaic Company (MOS) Q2 2026 Earnings Call Transcript

Mosaic posted a Q2 adjusted earnings beat, but weaker sales, lower volumes and higher sulfur costs hurt results as it cut 2026 capex guidance.

TAMPA, Fla., Aug. 4, 2026 /PRNewswire/ -- The Mosaic Company (NYSE: MOS) released its financial results for the second quarter of 2026.

Mosaic (MOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Mosaic Company is upgraded to Strong Buy, with valuation and asset quality offering compelling risk-reward amid macro headwinds. Despite Q1 losses and cost pressures from Middle East conflict, MOS is proactively cutting costs, deferring CAPEX, and maintaining financial flexibility. Significant upside exists from the Ma'aden stake and the Uberaba rare earths project, with potential for further value unlocks from capital reallocation.

TAMPA, Fla., July 15, 2026 /PRNewswire/ -- The Mosaic Company (NYSE: MOS) plans to release second quarter 2026 earnings results on Tuesday, August 4th, following the close of trading on the New York Stock Exchange.